Liabilities / Assets
78th percentile
Higher debt load relative to assets than 78% of similar nonprofits.
Siviq Scores
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
0.30x
Liabilities / Revenue
86th percentile
Higher debt load relative to revenue than 86% of similar nonprofits.
Net Margin
69th percentile
Higher net margin than 69% of similar nonprofits.
Top Officer Pay
Score unavailable
This filing does not contain officer compensation rows.
Asset Growth
62nd percentile
Faster asset growth than 62% of similar nonprofits.
Revenue Growth
88th percentile
Faster revenue growth than 88% of similar nonprofits.
Balance Sheet
Assets
Up$650,125
Up $39,510 (+6.5%) from 2017
Net Assets
Down$457,451
Down $56,204 (-11%) from 2017
Liabilities
Up$192,674
Up $95,714 (+99%) from 2017
Revenue And Expenses
Revenue
Up$335,573
Up $121,326 (+57%) from 2017
Expenses
Up$291,603
Up $224,327 (+333%) from 2017
Net Income
Down$43,970
Down $103,001 (-70%) from 2017
Historical Trend
Filing Detail Status
This 2018 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.
Jump To
Filing Snapshot
- Filing Period
- Jan 1, 2018 to Dec 31, 2018
Mission and Program Overview
Mission
Oligo nation advocates and fundraises to support medical research into oligodendroglioma brain cancer. We engage with others in the oligodendroglioma community to raise money and we work with researchers and research institutions to identify opportunities to fund translational research that can potentially lead to new treatments in the next 5 years.
Document Assets
No mirrored PDF or thumbnail assets are attached yet.
Filings
Displayed year
2018 • Form 990Summary only. Only limited summary data is available for this year.
- Assets
- $650,125
- Liabilities
- $192,674
- Net assets
- $457,451
- Revenue
- $335,573
- Expenses
- $291,603
- Net income
- $43,970